AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 143 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $739,850 | -63.6% | 115,964 | -36.7% | 0.00% | -100.0% |
| Q2 2023 | $2,030,202 | +62.8% | 183,066 | +125.4% | 0.00% | – |
| Q1 2023 | $1,246,942 | -65.9% | 81,234 | -50.8% | 0.00% | -100.0% |
| Q4 2022 | $3,661,084 | +704.6% | 164,988 | +493.0% | 0.00% | – |
| Q3 2022 | $455,000 | -23.8% | 27,821 | -32.3% | 0.00% | – |
| Q2 2022 | $597,000 | -64.4% | 41,079 | -54.8% | 0.00% | -100.0% |
| Q1 2022 | $1,678,000 | -14.2% | 90,866 | +10.5% | 0.00% | 0.0% |
| Q4 2021 | $1,955,000 | +110.7% | 82,228 | +118.2% | 0.00% | – |
| Q3 2021 | $928,000 | +887.2% | 37,686 | +886.5% | 0.00% | – |
| Q2 2021 | $94,000 | -86.0% | 3,820 | -87.6% | 0.00% | – |
| Q1 2021 | $673,000 | +1273.5% | 30,876 | +1527.6% | 0.00% | – |
| Q4 2020 | $49,000 | – | 1,897 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |